Multidrug Resistance Tuberculosis (MDR-TB) And Pre-Extensively Resistant Tuberculosis (Pre-XDR TB) In A 27 Year Old TB/HIV Co-Infected Patient In Ibadan, Oyo State, Nigeria A Case Report

The network to monitor the spread of multidrug resistance tuberculosis (MDR-TB) in Spain based on genomic typing and set up in January 1998 benefits from the participation of about 90% of the laboratories of the national health system. Of the 94 MDR-TB pa

Download Full-text

Extra-Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Presenting As Psoas Abcess: A Rare Case Report

Journal of Medical Science And clinical Research ◽

10.18535/jmscr/v6i2.146 ◽

2018 ◽

Vol 6 (2) ◽

Author(s):

Dr K B Gupta ◽

Keyword(s):

Case Report ◽

Rare Case ◽

Multidrug Resistant ◽

Resistant Tuberculosis ◽

Multidrug Resistant Tuberculosis ◽

Rare Case Report ◽

Mdr Tb ◽

Extra Pulmonary

Download Full-text

Factors Associated with Multidrup-Resistant Tuberculosis

Ibrahim Medical College Journal ◽

10.3329/imcj.v3i1.2917 ◽

1970 ◽

Vol 3 (1) ◽

pp. 29-33 ◽

Cited By ~ 3

Author(s):

Md Nurul Amin ◽

Md Anisur Rahman ◽

Meerjady Sabrina Flora ◽

Md Abul Kalam Azad

Keyword(s):

Multidrug Resistance ◽

Multidrug Resistant ◽

Tuberculosis Patients ◽

Face To Face ◽

Control Programs ◽

Resistant Tuberculosis ◽

Multidrug Resistant Tuberculosis ◽

Mdr Tb ◽

Directly Observed Treatment ◽

Sputum Conversion

This case control study was conducted in selected centers of Dhaka City from March to July 2008 to determine the association of multidrug-resistant tuberculosis with the attributes related to treatment and socio-economic condition of tuberculosis patients. Sixty seven culture-proven multidrug-resistant tuberculosis cases and similar number of age and sex matched controls were selected purposively. Data were collected by face to face interview and documents' review, using a pre tested structured questionnaire and a checklist. Multidrug-resistance was found to be associated with occupation (p=0.001) and residential status (p=0.001) of the tuberculosis patients. Tuberculosis patients who did not remain under directly observed treatment were 3 times more likely to develop multidrugresistant tuberculosis (OR 3.21, 95%CI=1.59-6.52). Multidrug-resistance was associated with inadequacy of treatment (OR 2.56, 95%CI=2.03-3.23). Failure of sputum conversion at the end of 2 months of treatment was detected to be the best predictor of multidrug-resistant tuberculosis (OR 11.82, 95% CI=4.61-30.33), followed by treatment with non Directly Observed Treatment Short course regimen and high labor intensive occupations like agriculture, production and transport. The risk factors of multidrug-resistant tuberculosis warrant much improvement in the effective implementation of control programs. Ibrahim Med. Coll. J. 2009; 3(1): 29-33 Key wards: Tuberculosis, MDR TB. doi: 10.3329/imcj.v3i1.2917

Download Full-text

KALIUM DI MULTIDRUG RESISTANCE TUBERKULOSIS DENGAN PENGOBATAN KANAMISIN (Potassium in Multidrug Resistance Tuberculosis with Kanamycin)

INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY ◽

10.24293/ijcpml.v21i1.1252 ◽

2018 ◽

Vol 21 (1) ◽

pp. 16 ◽

Cited By ~ 1

Author(s):

J.B. Suparyatmo ◽

B. Rina AS ◽

Harsini Harsini ◽

Sukma Sukma

Keyword(s):

Multidrug Resistance ◽

Potassium Level ◽

Multidrug Resistant ◽

Resistant Tuberculosis ◽

Multidrug Resistant Tuberculosis ◽

Before And After ◽

Mdr Tb ◽

The Difference ◽

Antibiotic Agents

Multidrug-Resistant Tuberculosis (MDR-TB) with bacillary resistance to at least isoniazid and rifampicin in vitro is a worldwidephenomenon. For MDR-TB second-line antibiotic agents that are more potent and more toxic must be used. . One of them is kanamycingiven intravenously every day for six (6) months therapy. Kanamycin is nephrotoxic and can lead to hypokalemia. This study is carriedout to know the comparison between the potasium level before and after kanamycin therapy (2, 4 and 6 months after therapy). Thisstudy is a cohort retrospective design, comprising 34 patients who had a potassium baseline before therapy in Moewardi Hospital,Surakarta from January 2011–August 2012. The characteristic data included: age, sex, weight and comorbidity. The potassium levelafter 2, 4 and 6 months post therapy was compared with the potassium data baseline using One Way ANOVA test with p< 0.05, CI95%. The difference between the potassium level after 6 months therapy and potassium baseline was significant, p < 0.05. However,the difference of the kalium level after 2 and 4 months after therapy was not significant, p > 0.05. Hypokalemia occurred in 6 patientsafter 2 months therapy, 8 patients after 4 months therapy and 3 patients after 6 months therapy. There was a significant differencebetween the potassium level after 6 months therapy and potassium baseline. Further study should be continued to know the existenceof hypokalemia among MDR-TB patients

Download Full-text

OTOTOXICITY IN MDR-TB PATIENTS ON CATEGORY-4 REGIMEN: A CASE REPORT

Era s journal of medical research ◽

10.24041/ejmr2020.45 ◽

2020 ◽

Vol 7 (2) ◽

pp. 257-259

Author(s):

Tanish Baqar ◽

Sharique Ahmad ◽

Silky Rai

Keyword(s):

Case Report ◽

Large Scale ◽

Multiple Drug Resistance ◽

Multiple Drug ◽

Drug Resistant ◽

Drug Resistant Tuberculosis ◽

Medical Progress ◽

Resistant Tuberculosis ◽

Multiple Drug Resistant ◽

Mdr Tb

Multiple drug-resistant tuberculosis (MDR-TB) is a critical situation affecting adults as properly as children across the globe (1). To determine the incidence and risk factors associated with Multiple Drug Resistant Tuberculosis (MDR-TB) (2), we studied Ototoxicity on 18 culture confirmed MDR-TB patients in Eras' Lucknow Medical College and Hospital, Lucknow from September, 2019 to January, 2020. This case follows a well documented report of a patient describing an unusual and novel occurrence of ototoxicity when undergoing treatment concerning multiple drug resistance tuberculosis along with symptoms, signs, diagnosis, treatment and follow-up (3). For descriptive convenience, the patient will be classified as patient 1. The following case is the cornerstones of medical progress and provides many new ideas in medicine. Containing an extensive review of the relevant literature on the topic, the case report is a rapid short communication between busy clinicians who may not have time or resources to conduct large scale research.(4)

Download Full-text